Escitalopram Oxalate
Product Images NDC 68071-3265

This is a table presenting the treatment-emergent adverse reactions observed with a frequency of more than 2% and greater than placebo for major depressive disorder. The table shows the percentage of adverse reactions for Escitalopram Oxalate and Placebo for Autonomic Nervous System Disorders, Central & Peripheral Nervous System Disorders, Gastrointestinal Disorders, General, Psychiatric Disorders, Respiratory System Disorders, and Urogenital. The adverse reactions include dry mouth, sweating increased, dizziness, diarrhea, constipation, indigestion, abdominal pain, influenza-like symptoms, fatigue, insomnia, somnolence, appetite decreased, libido decreased, rhinitis, sinusitis, ejaculation disorder, impotence and anorgasmia. There is some additional information provided for the male and female denominator for Ejaculation Disorder and Anorgasmia.*

This is a table presenting the adverse reactions observed in patients with Generalized Anxiety Disorder who were treated with Escitalopram compared to placebo. The adverse reactions observed with a frequency of greater than 2% and greater than placebo are listed by body system. Adverse reactions observed include gastrointestinal disorders, psychiatric disorders, musculoskeletal system disorders, respiratory system disorders, and others. Primarily ejaculatory delay was observed in males and menstrual disorder was observed in females.*

This is a description of a medication called Escitalopram 10mg, which comes in a bottle containing 30 film-coated tablets. The label includes information such as the lot and serial number, expiration date, manufacturer's NDC, and the drug's GTIN. The label also cautions that the medication should be kept out of reach of children and stored at a controlled temperature of 68-77°F. It advises to call a doctor for medical advice and reports of side effects can be made to the FDA.*